• SENSEX 76,496.76
    -258.29 (--0.34%)
  • BANKNIFTY 57,126.80
    -708.55 (--1.23%)
  • Bharti Airtel
    1,936.05 1,745.00(%)
  • Bluestone Jewel
    832.00 872.60(%)
  • Oracle Fin.Serv.
    11,394.75 11,986.90(%)
  • Gandhar Oil Ref.
    279.00 245.00(%)
  • Dr Reddy's Labs
    1,080.05 1,149.00(%)
  • Nippon ETF Liq.
    1,000.01 1,010.50(%)
  • SBI Funds Mgt.
    575.35 582.55(%)
  • Kalyan Jewellers
    588.60 327.15(%)
  • Eternal
    291.30 368.40(%)
  • Data Pattern
    4,672.60 2,131.00(%)
  • Adani Green
    1,403.00 767.00(%)
  • Tanla Platforms
    623.75 765.75(%)
  • Millworks Technologies
    727.95 693.30(%)
  • H P C L
    376.80 316.20(%)
  • HDFC Bank
    746.00 726.75(%)
  • Cupid
    211.00 225.90(%)
  • Reliance Industries
    1,277.85 1,253.65(%)
  • Uflex
    515.00 609.95(%)
  • IndusInd Bank
    1,019.65 710.85(%)
  • Bandhan Bank
    176.00 220.70(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

NGL Fine Chem Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Indian Private
  • BSE Code : 4558.0
  • ISIN : INE887E01022
3,256.20 19 (0.58%)
  • As on 23 Jul 2026 (EOD)

  • Today’s Low

    3,132.00

  • Today’s High

    3,270.00

  • Open

    3,230.30

  • Perv Close

    3,237.40

  • 52W Low

    1,175.50

  • 52W High

    3,329.00

Key Indicators

  • P/E(TTM)

    48.41

  • Mar.Cap (₹Cr.)

    2,012.33

  • Div & Yield %

    0.05

  • Book Value(₹)

    517.70

  • Debt-Equity Ratio

    0.58

  • AGM Date

    22-Jul-2026

  • EPS

    67.37

  • P/E Ratio

    48.41

Financials Ratios

  • Debt-Equity Ratio

    0.14

  • Mar.Cap (₹Cr.)

    2,012.33

  • RONW (%)

    17.03

  • ROCE (%)

    20.16

Score Board

  • Equity (₹ in Cr.)

    3.09

  • BV (₹)

    517.70

  • Sales( ₹ in Cr.)

    488.77

  • NP (in Cr.)

    41.63

  • NP Var(%)

    130.0

  • Div%

    35.0

  • CPS (₹)

    93.70

  • EPS (₹)

    67.40

  • Traded Value (₹ in Lakhs)

    2,015.67

  • 52 Week High

    3,329.00

  • 52 Week Low

    1,175.50

  • Price BSE

    3262.0

  • Price NSE

    3,256.00

  • Market Capital( in Cr.)

    2,015.67

  • P/C Ratio

    34.80

  • P/E Ratio

    48.40

  • Price Vs.BV

    67.40

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 359.29 328.97 275.05 318.67 258.18 152.18
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 359.29 328.97 275.05 318.67 258.18 152.18
Other Income 9.76 15.90 7.61 12.64 8.55 3.34
Stock Adjustments -1.36 12.06 -23.29 22.03 -1.86 5.39
Total Income 367.69 356.93 259.37 353.34 264.87 160.91
EXPENDITURE :            
Raw Materials 186.20 169.05 118.84 172.92 102.77 71.46
Power and Fuel Cost 20.48 18.60 15.45 14.47 9.27 9.75
Employee Cost 50.71 41.32 34.25 33.05 27.24 23.81
Other Manufacturing Expenses 53.17 47.44 37.17 41.21 26.49 18.50
Selling and Administration Expenses 15.33 14.51 11.24 8.56 11.52 7.94
Miscellaneous Expenses 5.47 5.34 6.09 4.57 1.98 5.19
Employee Benefit Expenses 50.71 41.32 34.25 33.05 27.24 23.81
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 331.37 296.27 223.05 274.77 179.27 136.66
Operating Profit 36.33 60.66 36.33 78.56 85.59 24.24
Interest 3.18 1.80 1.83 1.91 2.20 2.62
Gross Profit 33.15 58.86 34.50 76.65 83.39 21.62
Depreciation 9.27 8.15 7.90 7.67 7.39 7.27
Profit Before Tax 23.88 50.71 26.60 68.98 76.00 14.35
Current Tax 5.34 11.41 7.21 17.15 19.07 4.94
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.41 0.78 -0.73 -0.42 1.46 -1.19
Reported Net Profit 18.13 38.52 20.12 52.25 55.47 10.60
Extraordinary Items 0.00 0.00 0.00 0.00 0.00 -1.49
Adjusted Net Profit 18.13 38.52 20.12 52.25 55.47 12.09
Adjustment below Net Profit -0.24 -0.15 -0.08 -0.05 -0.14 -0.44
P & L Balance brought forward 257.51 220.22 201.27 150.15 95.91 86.82
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 1.08 1.08 1.08 1.08 1.08 1.08
P & L Balance carried down 274.31 257.51 220.22 201.27 150.15 95.91
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 35.00 35.00 35.00 35.00 35.00 35.00
Dividend Per Share(Rs) 1.75 1.75 1.75 1.75 1.75 1.75
Earnings Per Share-Unit Curr 29.35 62.35 32.57 84.57 89.79 17.16
Earnings Per Share(Adj)-Unit Curr 29.35 62.35 32.57 84.57 89.79 17.16
Book Value 452.60 425.39 365.04 334.36 251.62 163.81
Book Value(Adj)-Unit Curr 452.60 425.39 365.04 334.36 251.62 163.81

Shareholding Pattern

  • Promoter Group

    72.74%

  • Public Share Holding

    27.26%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 517,871 8.38 517,871 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 3,975,775 64.35 3,975,775 4
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 4,493,646 72.74 4,493,646 5
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 1,684 0.03 1,684 3
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 1,684 0.03 1,684 3
2] Non Institution
Bodies Corporate 97,463 1.58 88,963 77
Clearing Members 15,085 0.24 15,085 15
Directors of their Relatives 7,950 0.13 7,950 3
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 44,779 0.72 44,779 369
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 112,916 1.83 112,916 263
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 0 0.00 0 0
Individuals holding nominal share capital up to Rs. 1 lakh 1,400,213 22.66 1,216,166 11,768
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 1,000 0.02 1,000 2
Others 0 0.00 0 0
Sub Total 1,682,694 27.24 1,489,847 12,508
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 6,178,024 100.00 5,985,177 12,516

Company Background

NGL Fine Chem LtdPharmaceuticals - Indian - Bulk Drugs

  • NGL Fine Chem Ltd
  • BSE Code : 4558.0
  • ISIN : INE887E01022

  • Incorporation Year

    1981

  • Registered Office

    301 E Square Subhash Road
    Vile Parle (East), Mumbai,
    Maharashtra-400057

  • Telephone

    +91-22-2663 6450

  • FAX

  • Chairman

    Dhananjay N Mungale

  • Managing Director

  • Company Secretary

    Shivam Gharat

  • Auditor

    Manek & Associates

  • Face Value

    5

  • Listing

    NSE

  • Registrar

    Purva Sharegistry (India) Pvt
    Shiv Shakti Indust,
    Unit No 9 Lower Pare,7 B J R Boricha Marg
    Mumbai - Mumbai-400011

NGL Fine Chem Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
NGL Fine Chem 3,261.60 369.05 359.29 48.41 8.20
P & G Health Ltd 6,718.20 944.52 934.17 34.11 71.75
Sanofi India 3,403.50 1,857.10 1,837.40 25.30 54.17
Glaxosmi. Pharma 2,551.10 3,932.76 3,790.20 42.71 58.17
J B Chemicals & 2,412.25 3,945.17 3,889.89 57.46 24.24
Novartis India 1,699.05 398.23 356.27 45.02 16.64
Cipla 1,415.10 20,102.60 18,979.95 32.52 13.88
Amrutanjan Healt 529.35 469.50 451.82 26.43 21.89
Bliss GVS Pharma 448.15 773.53 729.81 49.09 12.51
Guj. Themis Bio. 351.75 152.47 150.80 82.18 27.21
Ambalal Sarabhai 31.49 19.52 3.94 22.02 6.77